18 Results for "

NIK kinase

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "NIK kinase" in MCE Product Catalog:

19
19 Publications Verification
Cat. No.: HY-120501
CAS No.: 1202764-53-1
Purity:  99.37%
Target:  

NF-κB

Research Areas:  

Inflammation/Immunology

B022 is a potent and selective NF-κB-inducing kinase (NIK) inhibitor (Ki of 4.2 nM; IC50=15.1 nM). B022 protects liver from toxin-induced inflammation, oxidative stress, and injury . B022 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-112433
CAS No.: 1660114-31-7
Purity:  99.95%
Target:  

NF-κB

Research Areas:  

Inflammation/Immunology

NIK SMI1 is a potent, selective NF-κB inducing kinase (NIK) inhibitor, which inhibits NIK-catalyzed hydrolysis of ATP to ADP with IC50 of 0.23±0.17 nM. NIK SMI1 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-145801
CAS No.: 2582816-37-1
Purity:  99.48%
Target:  

NF-κB

Research Areas:  

Inflammation/Immunology

XT2 is a potent, orally active, and selective inhibitor of NF-κB-inducing kinase (NIK) with an IC50 of 9.1 nM. XT2 suppresses CCl4-induced upregulation of ALT, a key biomarker of acute liver injury. XT2 also decreases immune cell infiltration into the injured liver tissue. XT2 has the potential for the research of liver inflammatory diseases . XT2 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-153516
CAS No.: 1202763-91-4
Target:  

NF-κB

Research Areas:  

Cancer

NIK-IN-2 (compound 1) is a potent inhibitor of NF-κB-inducing kinase (NIK), with the pIC50 of 7.4. NIK-IN-2 plays an important role in cancer research .
loading...
    loading...
Cat. No.: HY-112433A
CAS No.: 2984765-48-0
Purity:  99.28%
Target:  

NF-κB Drug Isomer

Research Areas:  

Inflammation/Immunology

(S)-NIK SMI1 is the isomer of NIK SMI1 (HY-112433), and can be used as an experimental control. NIK SMI1 is a potent, selective NF-κB inducing kinase (NIK) inhibitor, which inhibits NIK-catalyzed hydrolysis of ATP to ADP with IC50 of 0.23±0.17 nM.
loading...
    loading...
Cat. No.: HY-172545
CAS No.: 1202764-07-5
Target:  

Tau Protein

Research Areas:  

Neurological Disease

AMG28 is an ATP-competitive inhibitor targeting TTBK1 and TTBK2, with IC50 values of 805 nM and 988 nM, respectively. AMG28 inhibits the phosphorylation of tau protein at the Ser422 site .
loading...
    loading...
Cat. No.: HY-176061
Target:  

NF-κB

Research Areas:  

Cancer

NIK ligand 1 (compound 2) is a NF-κB inducing kinase (NIK) ligand .
loading...
    loading...
Cat. No.: HY-149696
CAS No.: 2387927-74-2
IR-Crizotinib is a NF-κB-inducing kinase (NIK) inhibitor that crosses the blood-brain barrier and fluorescently localizes intracranial glioblastoma (GBM) in mice (IC50=3.381 μM). IR-Crizotinib is conjugated from the near-infrared dye IR-786 and the NF-κB-inducing kinase (NIK) inhibitor Crizotinib. IR-Crizotinib can effectively inhibit the growth and invasion of glioma in vitro and in vivo and can be used in cancer research .
loading...
    loading...
Cat. No.: HY-149043
CAS No.: 1451079-18-7
Target:  

NF-κB

Research Areas:  

Metabolic Disease

NIK-IN-1 (Compound 2) is an inhibitor of NF-κB-inducing kinase (NIK). NIK-IN-1 is used for research on hepatic inflammatory diseases and acute liver injury .
loading...
    loading...
Cat. No.: HY-124865
CAS No.: 2113617-02-8
Target:  

MAP3K IKK

Research Areas:  

Cancer

MAP3K14-IN-1 (Compound 173) is a MAP3K14 (NIK kinase) inhibitor with an IC50 of 1.8 nM. MAP3K14-IN-1 inhibits the autophosphorylation of MAP3K14 kinase. MAP3K14-IN-1 reduces the level of phosphorylated IKKα in cancer cells. MAP3K14-IN-1 inhibits the proliferation of multiple myeloma cells. MAP3K14-IN-1 can be used in research related to multiple myeloma .
loading...
    loading...
Cat. No.: HY-179701
NIK-IN-3 is a potent and orally active NF-κB-inducing kinase (NIK) inhibitor with an IC50 of 5.2 nM. NIK-IN-3 suppresses non-canonical NF-κB pathway activation and inhibits the secretion of pro-inflammatory cytokines, such as TNF-α, IL-6, IL-1β and chemokine CXCL12. NIK-IN-3 shows significant anti-inflammatory effects in LPS (HY-D1056)-induced sepsis mice model and DSS (HY-116282)-induced colitis model. NIK-IN-3 can be used for the research of inflammation, such as colitis .
loading...
    loading...
Cat. No.: HY-P81378
Synonyms: MAP4K4; HGK, KIAA0687, NIK; Mitogen-activated protein kinase kinase kinase kinase 4; HPK/GCK-like kinase HGK; MAPK/ERK kinase kinase kinase 4 (MEK kinase kinase 4; MEKKK 4); Nck-interacting kinase

Host:  

Rabbit

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P85200
Synonyms: MAP4K4; HGK; KIAA0687; NIK; Mitogen-activated protein kinase kinase kinase kinase 4; HPK/GCK-like kinase HGK; MAPK/ERK kinase kinase kinase 4; MEK kinase kinase 4; MEKKK 4; Nck-interacting kinase

Host:  

Mouse

Application:  

WB, FC, ELISA

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-P81378A
Synonyms: MAP4K4; HGK, KIAA0687, NIK; Mitogen-activated protein kinase kinase kinase kinase 4; HPK/GCK-like kinase HGK; MAPK/ERK kinase kinase kinase 4 (MEK kinase kinase 4; MEKKK 4); Nck-interacting kinase

Host:  

Rabbit

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P705586
Purity:  ≥ 95%, as determined by reducing SDS-PAGE
Synonyms: MAP3K14; Serine/Threonine-Protein kinase NIK; Mitogen-Activated Protein kinase kinase kinase 14; NF-Kappa-Beta-Inducing kinase; NIK; Serine/Threonine Protein-kinase; FTDCR1B; IMD112; HSNIK; HsNIK; HS
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-P85200A
Synonyms: MAP4K4; HGK; KIAA0687; NIK; Mitogen-activated protein kinase kinase kinase kinase 4; HPK/GCK-like kinase HGK; MAPK/ERK kinase kinase kinase 4; MEK kinase kinase 4; MEKKK 4; Nck-interacting kinase

Host:  

Mouse

Application:  

WB, FC, ELISA

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-117222
CAS No.: 1202764-61-1
Target:  

NF-κB

Research Areas:  

Inflammation/Immunology Cancer

AM-0216 is a highly selective NF-κB-inducing kinase (NIK) inhibitor with a Ki value of 2 nM. AM-0216 is promising for research of NF-κB-dependent hematologic malignancies (e.g., multiple myeloma) and autoimmune diseases .
loading...
    loading...
Cat. No.: HY-P702743
Purity:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: MAP4K4; Non-Specific Serine/Threonine Protein kinase; Mitogen-Activated Protein kinase kinase kinase kinase 4; Epididymis Secretory Protein Li 31; HGK; Ste20 Group Protein kinase HGK; NIK; Uncharacterized Protein MAP4K4; FLH21957; HPK/GCK-Like kinase; Hep
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
  • 1